Early-stage clinical drug development Archives

Molecular Dx

New Blood Test Helps Accurately Diagnose Bipolar Disorder

Chris Anderson -

October 25, 2023

News & Features

More than 1,000 New Druggable Cancer Targets Revealed by Base Editing Combined with Chemical Proteomics

Chris Anderson -

October 11, 2023

News & Features

Druggable Target Discovered in Immunotherapy-Resistant Triple-Negative Breast Cancer

Chris Anderson -

October 4, 2023

Biodesix has expanded its lung disease test franchise by acquiring Intagrated Diagnostics (Indi)

News & Features

Protein Uncovered Implicated in Lung Cancer Resistance to TKIs

Chris Anderson -

July 12, 2023

Molecular Dx

New Test to Guide HER2 Positive Prescribing for Breast Cancer Launched

Malorye Branca -

June 19, 2023

A microglia cell in the foreground. It plays an important role in the pathogenesis of Alzheimer's disease

Molecular Dx

Could a Tiny Molecule Be the New Target for Alzheimer’s Disease?

Alisa Kirkin -

June 16, 2023

News & Features

GSK acquires BELLUS Health and P2X3 Antagonist for $2 Billion

Malorye Branca -

April 18, 2023

Destruction of leukaemia cell in blood cancer

News & Features

New Target That May Prevent Blood Cancer Identified

Alisa Kirkin -

April 14, 2023

Protoplasmic and fibrous astrocytes, illustration

News & Features

Confo and Daiichi Ink Deal on GPCR Drug Discovery Platform

Malorye Branca -

March 31, 2023

Molecular Dx

Spatial Transcriptomics and Proteomics Integrated by New High-Throughput Method

Malorye Branca -

January 3, 2023

12 3...7 Page 1 of 7

Alto Neuroscience Gets One Step Closer to Precision Depression Treatment

Seattle Children’s CAR T Spinout BrainChild Bio Launches with a Focus…

Texas Children’s Hospital Delivers First Gene Therapy for Rett Syndrome

Separate Studies Show Why Some Prostate Cancers Become Resistant to Hormone…

Generative AI Experts Absci Partner with AstraZeneca to Develop Cancer Treatment

Early-stage clinical drug development

New Blood Test Helps Accurately Diagnose Bipolar Disorder

More than 1,000 New Druggable Cancer Targets Revealed by Base Editing Combined with Chemical Proteomics

Druggable Target Discovered in Immunotherapy-Resistant Triple-Negative Breast Cancer

Protein Uncovered Implicated in Lung Cancer Resistance to TKIs

New Test to Guide HER2 Positive Prescribing for Breast Cancer Launched

Could a Tiny Molecule Be the New Target for Alzheimer’s Disease?

GSK acquires BELLUS Health and P2X3 Antagonist for $2 Billion

New Target That May Prevent Blood Cancer Identified

Confo and Daiichi Ink Deal on GPCR Drug Discovery Platform

Spatial Transcriptomics and Proteomics Integrated by New High-Throughput Method

Related Content

Alto Neuroscience Gets One Step Closer to Precision Depression Treatment

Smartwatch Data Plus Digital Twin Framework Predicts Risk of Heart Disease and Heart Attack

Crohn’s Disease Biomarker Guideline Released

Mount Sinai Team Identify 4,729 Gene Clusters That Influence Progression of 32 Cancer Types